Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/2/2022
PharmaLex Group Opens New Offices in China
9/2/2022
NHC: China Completes Initial Phase of National Health Information Plat...
9/2/2022
CNNIC: China's Internet Users Exceed 1.05B by June 2022 with 99.6% Bei...
9/2/2022
SAMR Issues New Regulation on Online Drug Sales (with Summary)
9/2/2022
Drug R&D and Product Registration News Digest September 2022 (1)
9/2/2022
Recent Official and Executive Moves
9/2/2022
Targeting Novo Nordisk in China's Obesity Market with A Unique Proposi...
9/1/2022
Why Genentech Eyes on Jemincare's Androgen Receptor Degrader?
9/1/2022
NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
8/31/2022
Mayo Clinic, Hibiscus and Innoforce Announce Mayflower Cell and Gene T...
8/31/2022
Financial-related Company News Digest (August 2022)
8/31/2022
IQVIA: Chinese Hospital Drug Market Down 5.8% in Q2/2022
8/31/2022
Snapshot of Top Ten Drug Products by Representative Hospital Sales in ...
8/31/2022
BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
8/30/2022
USCBC 2022 Member Survey: China's COVID-19 Policies Are the Top Chall...
8/30/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (62...
8/30/2022
CDE Solicits Comments on Draft Technical Guidelines for Writing of Pha...
8/30/2022
RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...
8/30/2022
Noteworthy Drugs Expected To Be Approved in China in H2/2022 (PharmCub...
8/30/2022
InnoCare Revs Up For Next Phase With Strong Results, IPO Plan (The Bam...
8/30/2022
Henlius CEO Scouts for US PD-1 Partner Amid Fosun Unit's Pivot to Inno...
8/30/2022
Drug Discovery in China: A Snapshot of Recent Progress (ScienceDirect)
8/29/2022
A Look at the CDE's 2021 Drug Review Report
8/29/2022
CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...
8/29/2022
CDE Issues the List of Reference Formulations for GQCE Studies (57th B...
8/29/2022
Porton Advanced, Royaltech Accelerate Development of mRNA Drugs in Chi...
8/26/2022
NMPA Announces OTC Switch of Omeprazole Enteric-Coated Tablets
8/26/2022
Recent Official and Executive Moves
8/26/2022
Drug R&D and Product Registration News Digest August 2022 (4)
8/24/2022
Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...
Page:
73
/
719
Total number of articles:
21546
:
[First]
[<<]
[71]
[72]
[73]
[74]
[75]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit